BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30062820)

  • 1. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
    Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
    Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma.
    Itou RA; Uyama N; Hirota S; Kawada N; Wu S; Miyashita S; Nakamura I; Suzumura K; Sueoka H; Okada T; Hatano E; Tsutsui H; Fujimoto J
    Hum Pathol; 2019 Jan; 83():77-89. PubMed ID: 30172911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.
    Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ
    J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
    Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
    Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
    [No Abstract]   [Full Text] [Related]  

  • 10. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
    Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
    Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma.
    Aishima S; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Mod Pathol; 2008 Mar; 21(3):256-64. PubMed ID: 18192971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
    Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
    Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.
    Liu LZ; He YZ; Dong PP; Ma LJ; Wang ZC; Liu XY; Duan M; Yang LX; Shi JY; Zhou J; Fan J; Gao Q; Wang XY
    Oncotarget; 2016 Nov; 7(46):75210-75220. PubMed ID: 27655691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma.
    Ohira S; Sasaki M; Harada K; Sato Y; Zen Y; Isse K; Kozaka K; Ishikawa A; Oda K; Nimura Y; Nakanuma Y
    Am J Pathol; 2006 Apr; 168(4):1155-68. PubMed ID: 16565491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.